О. В. Муслимова
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP) · 26 works · 61 citations · h-index 2
Top works
- Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
- Interchangeability of levothyroxine sodium tablets
- Experimental Cell Line Models for Nephrotoxicity Screening
- Organic anion transporters and their influence on the toxicity of β-lactam antibiotics
- β-Lactam Antibiotics—Drug-Drug Interaction Mediated by Organic Anion Transporters OAT1 and OAT3
- Effect of Organic Anion Transporters on the Development of Nephrotoxicity in the Context of NSAIDs Use
- Some Aspects of Drug Induced Nephrotoxicity Assessment
- Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
- Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections
- Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
- Nephrotoxicity Biomarkers: Role and Significance in the Diagnosis of Drug-Induced Kidney Injury
- Плазма крови человека в производстве лекарственных средств: национальные особенности в аспекте гармонизации с мировыми фармакопейными требованиями
- Взаимозаменяемость препаратов, содержащих глибенкламид
- Prospects of using C3435T polymorphism in the ABCB1 gene encoding P-glycoprotein in personalised medicine
- Organo-protective effects of quinapril: pharmacogenetic aspects
- Изучение токсических эффектов антибиотиков группы цефалоспоринов на модели клеточной линии НЕК293
- Взаимозаменяемость препаратов левотироксина
- Полиморфизм гена MDR1 и риск развития острого инфаркта миокарда у больных ИБС
- Фармакогенетическое тестирование в оптимизации терапии сахарного диабета 2 типа препаратами сульфонилмочевины
- Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs